# Novo Nordisk CEO Defends Ozempic and Wegovy Prices on Capitol Hill ## Key Points: – Novo Nordisk CEO, Jerzy Gruhn, is preparing to testify before Capitol Hill regarding the pricing of Ozempic and Wegovy. – The company has faced scrutiny over the high costs of these medications, which are used for weight management. – Gruhn will likely highlight the significant investment in research and development that goes into creating these innovative treatments. – The focus will be on the value these medications bring to patients in terms of weight loss and overall health benefits. ### Hot Take: It is important to understand the value that medications like Ozempic and Wegovy bring to individuals struggling with weight management. The investments made by companies like Novo Nordisk in research and development ultimately lead to groundbreaking treatments that can improve the lives of many. If you are considering weight loss options, it may be worth exploring these innovative medications as part of a comprehensive approach to your health journey. Contact Mindful Evolution on our website https://yourmindfulevolution.com or call or text us at 954-639-9960 to learn more about how we can support you in achieving your weight loss goals. Weight Loss Disclaimer: Individual results may vary. Mindful Evolution provides telehealth services in the states of Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.